Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Protecting Athletes and Their Brands: Businesses Team Up to Combat Deepfakes and Boost NIL Opportunities
-
Digital Brands Announces 1-for-50 Reverse Stock Split
-
WTW Announces Regular Quarterly Dividend
-
Power to the Middle: No Labels Hosts National Conference Featuring Key U.S. House and Senate Allies and Over 600 Citizen Leaders from All 50 States
-
Mullen Subsidiary, Bollinger Motors, Announces Adding Bergey’s Truck Centers to Its Sales and Service Network
-
Jake P. Noch Family Office, LLC.. Secures Court Approval for Comprehensive Restructuring Plan of Alaska Pacific Energy Corp. (OTC: ASKE)
-
Orion180 Announces Competitive and Customizable Residential Flood Insurance Product
-
The Duke Endowment Intends to Distribute $5 Billion Over 15 Years, Marking a Century of Giving
-
Ivans Reveals Latest Findings from Annual Agency-Carrier Connectivity Trends Report
-
Aptean Wins 2024 Top Software & Tech Award
-
New Clinical Trial of eTNS for Pediatric ADHD to Commence at Denmark’s Center for Evidence-Based Psychiatry
-
Stanley Martin Purchases Land for New Townhome Community in Dekalb County, GA
-
Stop & Shop to Roll Out "Savings Station" Kiosks Across Its Stores, Making Savings Easier for Shoppers
-
Payscale Unveils 2024’s Top Jobs Before Incoming U.S. Administration Reshapes Job Market
-
Wix Releases AI Feature for Businesses to Engage with their Customers Online
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women’s Hospital
-
Annual Report 2023/24 RIAS A/S
-
New Developer Portal and AI-Driven Tools in Genesis Application Platform Improve Developer Productivity in Financial Markets
-
ROCKWOOL A/S – transactions in connection with share buy-back programme
-
Winterberry Group Research Examines Direct Mail Ad Spend, Demand Drivers Given Heightened Brand Interest in ‘Omnichannel’ Marketing Integration
-
WhiteBIT and Visa Launch the First-Ever Debit Card for Crypto Payments with Cashback for All Users
-
NeoVolta and Expion360 Announce LOI to Advance Battery Manufacturing and Product Design
-
Daktronics Comments on Presentation and Public Statements from Alta Fox
-
AITX’s RAD-I and RAD-R Announce Major Tech Launches in Q4 FY 2025
-
The Rizzler Teams up with Toy and Entertainment Brand MGA Entertainment for “MGA Presents: Diss-mas,” an Anthem About What Kids Really Want for the Holidays
-
Four Leaf Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
-
Rocketinvest.com: Setting the Standard for Online Investment Security
-
Tactical Resources Announces Amendment to Business Combination Agreement
-
Ethical Web AI Partners with BolgiaTen Limited to Transform Enterprise AI Training and Drive Revenue Growth
-
Schellman & Company, LLC Announces Carve Out Acquisition of Connor Consulting’s Third-Party Risk Management (TPRM) Practice
-
Brera Holdings PLC (NASDAQ: BREA) Grabbing Attention as Market Player with Unique Approach to Multi-Club Ownership
-
AmpliTech Group Powers The Quantum Computing Revolution With Cutting-Edge Low-Noise Cryogenic HEMT Amplifiers
-
Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Brera Holdings PLC (NASDAQ: BREA) Grabbing Attention as Market Player with Unique Approach to Multi-Club Ownership
-
Roadzen Partners with Cimarron Underwriters, LLC to Secure MGA Licensing Capabilities Across All 50 U.S. States
-
Vivopower Receives Notification of Recompliance with Nasdaq’s Minimum Bid Price Rule
-
BOSS Money Says ‘Thank You’ with Zero-Fee Money Transfers for the Holidays
-
Anaptys Announces Phase 2b Trial of ANB032, a BTLA Agonist, Did Not Meet Primary or Secondary Endpoints in Atopic Dermatitis
-
Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis
-
La Rosa Holdings Launches its First Office in North Carolina
-
Aprea Therapeutics Announces Twice Daily (BID) Dosing of Patients in ABOYA-119 Clinical Trial of ATRN-119 to Potentially Optimize Clinical Outcomes and Strengthen Clinical Path Forward
-
Foremost Clean Energy Issues Shareholder Letter Highlighting Recent Denison Transaction and Operational Updates
-
Gain Therapeutics To Present At Biotech Showcase 2025
-
SATO Corporation’s financial communications 2025
-
The Chertoff Group, SureScan and VMD Announce Joint Venture to Revolutionize Airport Security with Gigaplex (TM) Remote Screening Technology
-
Form 8.3 - Learning Technologies plc - Octopus Investments
-
Form 8.3 - Volex plc - Octopus Investments
-
Golden Grail Beverages Announces the Acquisition of UPDC Beverages
-
Genmab to Hold 2024 R&D Update and ASH Data Review Meeting
